Results 61 to 70 of about 298,452 (154)

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study

Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1650-1661, June 2026.
AGILE (NCT04746183) is a Phase Ib/IIa platform, evaluating candidates to treat COVID‐19. Candidate Specific Trial 6 evaluated the safety and optimal dose of a novel intravenous formulation of favipiravir in a dose‐escalating, open‐label, randomized, controlled, Bayesian adaptive Phase Ib trial.
Tim Rowland, Richard FitzGerald, Elizabeth Challenger, Laura Dickinson, Laura J. Else, Lauren Walker, Colin Hale, Victoria Shaw, Callum Kelly, Rebecca Lyon, Jennifer Gibney, Karim Dhamani, Margaret Irwin, Yvanne Enever, Michelle Tetlow, William Wood, Helen Reynolds, Justin Chiong, Orod Osanlou, Henry Pertinez, Katie Bullock, William Greenhalf, Andrew Owen, David G. Lalloo, Michael Jacobs, Julian A. Hiscox, Thomas Jaki, Pavel Mozgunov, Geoffrey Saunders, Gareth Griffiths, Saye H. Khoo, Thomas E. Fletcher, on behalf of the AGILE CST‐6 Study Group, Shazaad Ahmad, Christopher J. Edwards, Lesley Dry, Georgie McKenzie, Aleksandra Ros, Michael Stackpoole, Laura Bradley, Karen Jennings‐Wilding, Nicholas Paton, Fred Hayden, Janet Darbyshire, Amy Lucas, Ulrika Lorch, Andrew Freedman, Richard Knight, Steven Julious   +48 more
wiley   +1 more source

What we know about ocular manifestations of Ebola

Clinical Ophthalmology, 2014
Majid Moshirfar,1 Carlton R Fenzl,2 Zhan Li3 1Department of Ophthalmology, Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA; 2John A Moran Eye Center, University of Utah, Salt Lake City, UT, USA ...
Moshirfar M, Fenzl CR, Li Z
doaj  

The Problematic Diseases of viral Hemorrhagic Fever: Insights into Ebola, Marburg, and Dengue Fever Viruses [PDF]

ERU Research Journal
Viral Hemorrhagic Fever Diseases are critical health problems worldwide. Several outbreaks of hemorrhagic fever diseases have emerged in the last few years in different countries, particularly in tropical and subtropical regions of Africa, raising ...
Tharwat El-khamissy, Mohammed Abdo
doaj   +1 more source

Repurposed Medicines for Viruses With Epidemic or Pandemic Potential: A Horizon Scan

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT Viruses such as Ebola, Marburg, influenza, mpox, MERS‐CoV, SARS‐CoV, and SARS‐CoV‐2 may be considered pathogens of epidemic or pandemic concern. Developing novel antiviral medicines can be time‐consuming and resource intensive. Repurposing existing medicines with known or potential antiviral activity offers a faster, cost‐effective strategy to
Sola Akinbolade, Rhiannon Potter, Alex Inskip, Jane Nesworthy, Kirsti Brock, Gill Norman   +5 more
wiley   +1 more source

Infectious Disease Response in Tanzania: Enhanced Strategies From the 2023 to 2025 Marburg Outbreaks

Public Health Challenges, Volume 5, Issue 2, June 2026.
ABSTRACT The 2023 Marburg virus disease (MVD) outbreak in Tanzania, which resulted in nine confirmed cases and six deaths (case fatality rate [CFR]: 66.7%), served as a critical stress test of the national health system, revealing significant gaps in outbreak preparedness across surveillance, laboratory capacity, and infection prevention and control ...
Huda Haque, Faraan O. Rahim, Sameer Abbasi, Nam Nguyen, Erick Mahatara, Alison Jang, Ntuli A. Kapologwe   +6 more
wiley   +1 more source

Viral Hemorrhagic Fevers Other than Ebola and Lassa [PDF]

Infectious Disease Clinics of North America, 2019
Viral hemorrhagic fevers represent a group of diseases caused by enveloped RNA viruses. The epidemiology is broadly variable, ranging from geographically localized to more diffuse infections. Viral hemorrhagic fevers are classified as category A bioweapon agents by the Centers for Disease Control and Prevention.
Iannetta M., Di Caro A., Nicastri E., Vairo F., Masanja H., Kobinger G., Mirazimi A., Ntoumi F., Zumla A., Ippolito G.   +9 more
openaire   +4 more sources

Molecular Mechanisms of Ebola Virus Entry into Permissive Cells

Проблемы особо опасных инфекций, 2015
Ebola virus, representative of the Ebolavirus genus, Filoviridae family, causes severe hemorrhagic fever in humans, with lethality rates amounting up to 90 %. The members of Ebolavirus genus infect a broad range of mammalian cells.
T. E. Sizikova, V. N. Lebedev, V. B. Pantyukhov, S. V. Borisevich   +3 more
doaj   +1 more source

Mystery Disease X Outbreak in the Democratic Republic of the Congo: A Narrative Review of Epidemiological Patterns and Response Challenges

Health Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims An unknown disease known as Disease X first surfaced in the Panzi Health Zone, Kwango Province, Democratic Republic of the Congo (DRC), towards the end of 2024. It mainly affected children under the age of five. The clinical characteristics and of the outbreak are examined in this review.
Muhammad Shaheer Bin Faheem, Muhammad Haroon‐Ul‐Rasheed, Sumaya Samadi   +2 more
wiley   +1 more source

Fractional Order Epidemic System of Saturated Rate of Incidence: A Neural Network Approach

Engineering Reports, Volume 8, Issue 3, March 2026.
The workflow depictions of the mathematical fractional order saturated rate of incidence model using the process of Levenberg–Marquardt Backpropagation neural network. The designed neural network contains 20 numbers of neurons, a sigmoid activation function, and a single hidden layer structure.
Zulqurnain Sabir, M. A. Abdelkawy, Muhammad Umar, Soheil Salahshour   +3 more
wiley   +1 more source

Ecologic and Geographic Distribution of Filovirus Disease

Emerging Infectious Diseases, 2004
We used ecologic niche modeling of outbreaks and sporadic cases of filovirus-associated hemorrhagic fever (HF) to provide a large-scale perspective on the geographic and ecologic distributions of Ebola and Marburg viruses.
A. Townsend Peterson, John T. Bauer, James N. Mills   +2 more
doaj   +1 more source